首页> 外文会议>Conference on Applications of Digital Image Processing >IR spectrum comparison of the blood of breast cancer patients as a preliminary stage of further molecular genetic screening
【24h】

IR spectrum comparison of the blood of breast cancer patients as a preliminary stage of further molecular genetic screening

机译:乳腺癌患者血液的IR谱比较作为进一步分子遗传筛查的初步阶段

获取原文

摘要

The aim of this paper is to study BRCA1 - 185delAg and 5382insC gene mutations in breast cancer patients and their relatives to identify new directions for the prevention, diagnosis and treatment of breast cancer. As diagnostic methods have been used ultraviolet spectrometry samples of blood plasma in the liquid state, infrared spectroscopy middle range (2,5 - 25 microns) dry residue of plasma polarization and laser diagnostic technique of thin histological sections of biological tissues. Obtained results showed that the use of spectrophotometry in the range of 1000-3000 cm-1 allowed to establish quantitative parameters of the plasma absorption rate of blood of patients in the third group in different ranges, which would allow in the future to conduct an express analysis of the patient's condition (procedure screening) for further molecular-genetic typing on BRCA Ⅰ and Ⅱ.
机译:本文的目的是研究BRCA1 - 185delag和5382辛的基因突变在乳腺癌患者及其亲属中,以确定预防,诊断和治疗乳腺癌的新方向。由于诊断方法已在液态血浆中使用紫外光谱谱样品,红外光谱中间范围(2,5-25微米)的血浆偏振和激光诊断技术的生物组织薄组织部分的激光诊断技术。得到的结果表明,使用的分光光度法在1000-3000cm-1的范围内允许建立不同范围内第三组患者血液吸收率的定量参数,这将来会允许在未来进行快递患者病症(程序筛选)对BRCAⅠ和Ⅱ和Ⅱ的进一步分子遗传键入的分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号